Trials / Terminated
TerminatedNCT02095353
Comparison of Contrast Agents for MRI Perfusion Analysis in Brain Tumor Patients
Gadobenate Dimeglumine Compared to Gadobutrol for MRI Perfusion Analysis in Brain Tumor Patients
- Status
- Terminated
- Phase
- —
- Study type
- Observational
- Enrollment
- 6 (actual)
- Sponsor
- University of Nebraska · Academic / Other
- Sex
- All
- Age
- 19 Years
- Healthy volunteers
- Not accepted
Summary
This study will compare the use of two contrast agents to analyze blood flow characteristics of brain tumors.
Detailed description
This study will compare contrast agents, gadobenate dimeglumine and gadobutrol, for MRI perfusion analysis in brain tumor patients.
Conditions
Timeline
- Start date
- 2014-09-01
- Primary completion
- 2017-03-07
- Completion
- 2017-03-07
- First posted
- 2014-03-24
- Last updated
- 2023-08-23
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT02095353. Inclusion in this directory is not an endorsement.